IGC PHARMA, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
IGC PHARMA, INC. (IGC) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $1.65 million for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-18
- IGC PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $3.87M, a 175.39% increase from fiscal 2024.
- IGC PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $1.41M, a 53.16% decline from fiscal 2023.
- IGC PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $3.00M, a 13.93% decline from fiscal 2022.
- IGC PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $3.49M, a 79.61% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 9 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|---|
| 2025-12-31 | $1.65M 10-KT · filed 2026-03-18 | |
| 2025-03-31 | $3.87M 10-KT · filed 2026-03-18 | |
| 2024-03-31 | $1.41M 10-K · filed 2025-06-27 | |
| 2023-03-31 | $3.00M 10-K · filed 2024-06-24 | |
| 2022-03-31 | $3.49M 10-K · filed 2023-07-07 | |
| 2021-03-31 | $1.94M 10-K · filed 2022-06-23 | |
| 2020-03-31 | $4.38M 10-K · filed 2021-06-14 | |
| 2019-03-31 | $0.00 10-K · filed 2020-07-13 | |
| 2018-03-31 | $0.00 10-K · filed 2019-06-14 | |
| 2017-03-31 | $0.00 10-K · filed 2018-06-21 | |
| 2016-03-31 | $0.00 10-K · filed 2017-07-14 | |
| 2015-03-31 | $0.00 10-K · filed 2016-07-14 | |
| 2014-03-31 | $0.00 10-K · filed 2015-07-14 | |
| 2013-03-31 | $0.00 10-K · filed 2014-07-15 | |
| 2012-03-31 | -$4.75K 10-K · filed 2014-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |